Marco Daperno

9.1k citations

113 papers · 4.2k indexed · 2 hit papers · h-index 29

Impact in

Genetics top 0.2%
- Inflammatory Bowel Disease
Gastroenterology top 1%
- Gastrointestinal Bleeding Diagnosis and Treatment

Papers in

Genetics 90
- Inflammatory Bowel Disease 89
Gastroenterology 14

Co-authors: R. Sostegni A. Pera Rodolfo Rocca Geert D’Haens V. Maunoury Gert Van Assche P. Bulois Filip Baert
Journals: Digestive and Liver Disease (33 papers)Journal of Crohn s and Colitis (16 papers)Gastroenterology (8 papers)Gastrointestinal Endoscopy (5 papers)Alimentary Pharmacology & Therapeutics (5 papers)
Partner nations: Italy United States United Kingdom

In The Last Decade

Marco Daperno

108 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

European evidence based consensus for endoscopy in inflammatory bowel disease 2013 · 574 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Journal of Crohn s and Colitis
2004 Gastrointestinal Endoscopy

Peers

Countries citing papers authored by Marco Daperno

Since Specialization

Citations

This map shows the geographic impact of Marco Daperno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Daperno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Daperno more than expected).

Fields of papers citing papers by Marco Daperno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Daperno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Daperno. The network helps show where Marco Daperno may publish in the future.

Co-authors

The 25 scholars most cited alongside Marco Daperno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marco Daperno Line = papers co-authored together Marco Daperno links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn’s Disease Inflammatory Bowel Diseases ·Reena Khanna, Brian G. Feagan, Guangyong Zou, Larry Stitt, John WD McDonald, Brian Bressler, Remo Panaccione, Lisa M. Shackelton, 宮田佳英, Edward V. Loftus, Marco Daperno, Vipul Jairath, Geert D’Haens, William J. Sandborn	2024	2
2	Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program Advances in Therapy ·Michael Chiorean, Marco Daperno, Charlie W. Lees, Emilie C. Baker, Dimitrios Soudis, Irene Modesto, J. Jasper Deuring, Roger Edwards	2023	1
3	Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting Digestive and Liver Disease ·Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni, Gert Ten Ossenkoppele, Flavio Caprioli, Fernando Rizzello, Marco Daperno, Alessandro Armuzzi	2023	1
4	A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics Digestive and Liver Disease ·Luca Degli Esposti, Marco Daperno, Gert Ten Ossenkoppele, О. Л. Никонець, Diego Sangiorgi, Edoardo Savarino, Franco Scaldaferri, B. Veeresh, Andrea Serra, Valentina Perrone, Alessandro Armuzzi	2023	8
5	Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long‐term extension period of STARDUST Alimentary Pharmacology & Therapeutics ·Laurent Peyrin‐Biroulet, Séverine Vermeire, Geert D’Haens, Julián Panés, Axel Dignaß, Fernando Magro, María Fernanda Linda Sofía Colorado Barón, Manuela Le Bars, Marjolein Lahaye, Jane Tilley, Robert Campbell Moberley, F. Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R. Gaya, Silvio Danese	2023	9
6	Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus Digestive and Liver Disease ·Sandro Ardizzone, Alessandro Armuzzi, Flavio Caprioli, Fabiana Castiglione, Silvio Danese, Marco Daperno, Massimo Claudio Fantini, Walter Fries, Mariabeatrice Principi, Edoardo Savarino, Paolo Gionchetti	2023	4
7	Endoscopy in IBD: When and How? Diagnostics ·Marco Daperno	2023	10
8	Has the Removing of the Mesentery during Ileo-Colic Resection an Impact on Post-Operative Complications and Recurrence in Crohn’s Disease? Results from the Resection of the Mesentery Study (Remedy) Journal of Clinical Medicine ·Michela Mineccia, Giovanni Maconi, Marco Daperno, S Niko, Valeria Cherubini, F. Colombo, H. Wildhagen, Caterina Baldi, Paolo Massucco, Sandro Ardizzone, Alessandro Ferrero, Gianluca M. Sampietro	2022	9
9	Categorising Endoscopic Severity of Crohn’s Disease Using the Modified Multiplier SES-CD [MM-SES-CD] Journal of Crohn s and Colitis ·Neeraj Narula, J.C. Doughty, Emily C L Wong, Jean‐Frédéric Colombel, John K. Marshall, Marco Daperno, Walter Reinisch, Parambir S. Dulai	2022	13
10	Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial The Lancet. Gastroenterology & hepatology ·William J. Sandborn, Julián Panés, Silvio Danese, Carmen Gonzalez Romero, Aryan S. Asaad, Vincent B LESCH, Dong Cheng, Marco Daperno, John F. Valentine, David Laharie, Jun Shao, Raja Atreya, Remo Panaccione, Grażyna Rydzewska, Humberto Aguilar, Séverine Vermeire	2022	39
11	DOP90 Efficacy of the treat-to-target approach in modifying disease course with ustekinumab in patients with moderate-to-severe Crohn’s Disease: Results from the STARDUST trial Journal of Crohn s and Colitis ·Laurent Peyrin‐Biroulet, Séverine Vermeire, Geert D’Haens, Julián Panés, Axel Dignaß, Fernando Magro, Manuela Le Bars, Marjolein Lahaye, Payal Bhattacharya, Jane Tilley, Robert Campbell Moberley, F. Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R. Gaya, Silvio Danese	2022	2
12	Predicting endoscopic remission in Crohn’s disease by the modified multiplier SES-CD (MM-SES-CD) Gut ·Neeraj Narula, Emily C L Wong, Jean‐Frédéric Colombel, William J. Sandborn, John K. Marshall, Marco Daperno, Walter Reinisch, Parambir S. Dulai	2021	30
13	Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments Gut ·Klaus Gottlieb, Marco Daperno, Keith Usiskin, Bruce E. Sands, (unknown), Colin W. Howden, William E. Karnes, Young S. Oh, Irene Modesto, Colleen Marano, Ryan W. Stidham, Walter Reinisch	2020	44
14	P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program Journal of Crohn s and Colitis ·Marco Daperno, Michele Comberlato, Fabrizio Bossa, Andrea Bonanomi, Guido Lombardi, Livia Biancone, R. Cosintino, R. D’Incà, A. Cassinotti, R. Mangiarotti, Alfredo Papa, Roberta Pica, Fernando Rizzello, Alessandro Armuzzi, Ambrogio Orlando	2014	5
15	The diagnosis of inflammatory bowel disease is often unsupported in clinical practice Digestive and Liver Disease ·Gabriella Canavese, Vincenzo Villanacci, Anna Sapino, Rodolfo Rocca, Marco Daperno, Renzo Suriani, Francesca Maletta, Paola Cassoni	2014	11
16	Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study Inflammatory Bowel Diseases ·Livia Biancone, C. Petruzziello, Ambrogio Orlando, Anna Kohn, Sandro Ardizzone, Marco Daperno, Erika Angelucci, Fabiana Castiglione, R. D’Incà, Francesca Zorzi, Claudio Papi, Gianmichele Meucci, Gabriele Riegler, Giuseppe Sica, Fernando Rizzello, Filippo Mocciaro, Sara Onali, Emma Calabrese, Mario Cottone, Francesco Pallone	2010	35
17	Pregnancy before and after the diagnosis of inflammatory bowel diseases: Retrospective case–control study Journal of Gastroenterology and Hepatology ·Aurora Bortoli, Simone Saibeni, M. Tatarella, Alberto Prada, Luigi Beretta, Ahmad Solihun, 畅舒, P. Ravelli, G. Imperiali, Enrico Colombo, A. Pera, Marco Daperno, M Carnovali, Roberto de Franchis, Maurizio Vecchi, (unknown)	2006	62
18	The hazardous burden of Herpesviridae in inflammatory bowel disease: The case of refractory severe ulcerative colitis Digestive and Liver Disease ·A. Lavagna, Massimiliano Bergallo, Marco Daperno, R. Sostegni, Nicoletta Ravarino, Mohammad Hossein Sarfi, P. Srikant, Rodolfo Rocca, Bruno Torchio, Rossana Cavallo	2006	14
19	Medical treatment of severe ulcerative colitis Alimentary Pharmacology & Therapeutics ·Marco Daperno, R. Sostegni, Rodolfo Rocca, C. Rigazio, N. Scaglione, F. Castellino, E. Ercole, A. Pera	2002	39
20	Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it reliable diagnostic and prognostic marker? Digestive and Liver Disease ·R. Sostegni, Marco Daperno, E. Ercole, C. Rigazio, Francesca Bresso, 犬塚義, F. Castellino, Vikrant Kushwaha, Rodolfo Rocca, E. Taniş, Giorgia Della Rocca, Marco Astegiano, A. Pera	2001	17

About Marco Daperno

Marco Daperno is a scholar working on Genetics, Gastroenterology, Epidemiology, Surgery and Immunology, having authored 113 papers that have together received 4.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (89 papers), Microscopic Colitis (60 papers), Eosinophilic Esophagitis (15 papers), Immunodeficiency and Autoimmune Disorders (11 papers), Autoimmune and Inflammatory Disorders (10 papers), Helicobacter pylori-related gastroenterology studies (10 papers), Colorectal Cancer Screening and Detection (8 papers) and Pregnancy and Medication Impact (6 papers). The work is most often cited by research in Genetics (3.4k citations), Gastroenterology (534 citations), Epidemiology (2.6k citations), Surgery (1.7k citations) and Immunology (569 citations). Marco Daperno has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include R. Sostegni, A. Pera, Rodolfo Rocca, Geert D’Haens, V. Maunoury, Gert Van Assche, P. Bulois, Filip Baert, Vito Annese and A. Lavagna. Their work appears in journals such as Digestive and Liver Disease, Journal of Crohn s and Colitis, Gastroenterology, Gastrointestinal Endoscopy and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact